Serum lactate dehydrogenase as a novel prognostic factor for patients with primary undifferentiated pleomorphic sarcomas.
In: Journal of cancer research and clinical oncology, Jg. 149 (2023-04-01), Heft 4, S. 1453-1463
Online
academicJournal
Zugriff:
Purpose: Among soft tissue sarcomas, undifferentiated pleomorphic sarcoma (UPS) has relatively higher potential of recurrence and metastasis. As serum lactate dehydrogenase (LDH) is associated with tumor progression and unfavorable outcomes in multiple malignancies, we designed this study to explore the relationship between preoperative serum LDH and prognosis in UPS patients.
Methods: We extracted the data of UPS patients who underwent primary surgery in Shanghai Cancer Center, Fudan University. Receiver-operating characteristic (ROC) curve was used to figure out the best cutoff value of LDH to classify them into high- or low-expression groups. Univariate and multivariate analyses were performed using Cox proportional hazards regression to identify independent prognostic factors. Kaplan-Meier analysis was used to compare differences in overall survival (OS) and time to recurrence (TTR) between patients with high- or low-serum LDH.
Results: Multivariate analyses demonstrated that preoperative serum LDH was an independent factor for OS. Kaplan-Meier curves showed that patients with relatively high-serum LDH (P = 0.0004) had poorer OS compared with those with low-serum LDH. There was a trend that patients with relatively high-serum LDH had poorer TTR than those without (P = 0.1249). In addition, there were obvious trends that patients with decreased serum LDH after surgery showed better OS (P = 0.0954) and TTR (P = 0.1720) than those with elevated serum LDH. Moreover, high preoperative serum LDH was associated with female patients (P = 0.0004), positive margin (P < 0.0001), worse survival (P = 0.0061), higher mitotic index (P = 0.0222) and necrosis (P = 0.0225).
Conclusions: Preoperative serum LDH is an independent factor for OS in UPS patients, and it correlates with future surgical margin.
(© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
| Titel: |
Serum lactate dehydrogenase as a novel prognostic factor for patients with primary undifferentiated pleomorphic sarcomas.
|
|---|---|
| Autor/in / Beteiligte Person: | Lin, Q ; Sun, Z ; Yu, L ; Wang, Q ; Zhu, P ; Jiang, Y ; Sun, Y ; Yan, W |
| Link: | |
| Zeitschrift: | Journal of cancer research and clinical oncology, Jg. 149 (2023-04-01), Heft 4, S. 1453-1463 |
| Veröffentlichung: | Berlin ; New York : Springer-Verlag., 2023 |
| Medientyp: | academicJournal |
| ISSN: | 1432-1335 (electronic) |
| DOI: | 10.1007/s00432-022-04014-0 |
| Schlagwort: |
|
| Sonstiges: |
|